[1] NOTE:  As provided in LFC policy, this report is intended for use by the stand­ing finance committees of the legislature.  The Legislative Finance Committee does not assume responsibili­ty for the accuracy of the information in this report when used in any other situation.

 

Only the most recent FIR version, excluding attachments, is available on the Intranet.  Previously issued FIRs and attachments may be obtained from the LFC office in Suite 101 of the State Capitol Building North.

 

 

F I S C A L   I M P A C T   R E P O R T

 

 

 

SPONSOR:

Heaton

 

DATE TYPED:

01/21/02

 

HB

HB 41

 

SHORT TITLE:

Dispensing Controlled Substances

 

SB

 

 

 

ANALYST:

Joey F. Sandoval

 

APPROPRIATION

 

Appropriation Contained

Estimated Additional Impact

Recurring

or Non-Rec

Fund

Affected

FY02

FY03

FY02

FY03

 

 

 

 

NFI

 

 

 

 

(Parenthesis ( ) Indicate Expenditure Decreases)

 

Relates to Senate Bill 8 (Compassionate Use Medical Cannabis Act)

 

SOURCES OF INFORMATION

 

LFC Files

Board of Pharmacy

Health Policy Commission

 

SUMMARY

 

House Bill 41 is an amendment to the Controlled Substances Act that eliminates language allowing “practitioners” to obtain annual registration from their respective examining and licensing authorities.  Practitioners will be required to annually obtain registration from the Board of Pharmacy to distribute or dispense drugs that are subject to the Controlled Substances Act.     

 

     Significant Issues

 

 

 

 

 

 

OTHER SUBSTANTIVE ISSUES

 

·       May create additional bureaucratic burden for practitioners who renew registration at the same board in which they renew their license.  Since controlled substance registration is required annually and license renewal is not, in the years in which the license is not renewed, the burden would remain the same.

·       Streamlines the controlled substances registration process and reduces administrative burden on the Board of Pharmacy and other professional licensing boards by limiting the registration paper work to a single board.

·       May create the opportunity for the Board of Pharmacy to monitor the controlled substances registration process more closely.

·       If controlled substances registration is a licensure requirement of a practitioner licensing board, that board would now be required to verify registration by a practitioner with the Board of Pharmacy during the licensing process, potentially creating an administrative burden on that licensing board.

·       An automated process of registration verification between the Board of Pharmacy and practitioner licensing boards may be beneficial.

 

POSSIBLE QUESTIONS

 

 

JFS/njw:ar


 [1]Begin typing on the * in replace mode.  Do not add or delete spaces.